These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25082853)

  • 21. An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers.
    Brooks DJ; Papapetropoulos S; Vandenhende F; Tomic D; He P; Coppell A; O'Neill G
    Clin Neuropharmacol; 2010; 33(2):55-60. PubMed ID: 20375654
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine A(2A) receptor antagonists as Positron Emission Tomography (PET) tracers.
    Khanapur S; Waarde Av; Ishiwata K; Leenders KL; Dierckx RA; Elsinga PH
    Curr Med Chem; 2014; 21(3):312-28. PubMed ID: 24059232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Test-retest reproducibility of cerebral adenosine A
    Toyohara J; Sakata M; Wagatsuma K; Tago T; Ishibashi K; Ishii K; Elsinga P; Ishiwata K
    Ann Nucl Med; 2022 Jan; 36(1):15-23. PubMed ID: 34564828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
    Kolb HC; Barret O; Bhattacharya A; Chen G; Constantinescu C; Huang C; Letavic M; Tamagnan G; Xia CA; Zhang W; Szardenings AK
    J Nucl Med; 2019 Aug; 60(8):1154-1159. PubMed ID: 30733317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    Fazio P; Svenningsson P; Forsberg A; Jönsson EG; Amini N; Nakao R; Nag S; Halldin C; Farde L; Varrone A
    J Nucl Med; 2015 May; 56(5):714-20. PubMed ID: 25791993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A2A Adenosine Receptor Antagonists as Therapeutic Candidates: Are They Still an Interesting Challenge?
    Cacciari B; Spalluto G; Federico S
    Mini Rev Med Chem; 2018; 18(14):1168-1174. PubMed ID: 29692248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Striatal adenosine A(2A) receptor-mediated positron emission tomographic imaging in 6-hydroxydopamine-lesioned rats using [(18)F]-MRS5425.
    Bhattacharjee AK; Lang L; Jacobson O; Shinkre B; Ma Y; Niu G; Trenkle WC; Jacobson KA; Chen X; Kiesewetter DO
    Nucl Med Biol; 2011 Aug; 38(6):897-906. PubMed ID: 21843786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and Biological Evaluation of a Novel
    Lai TH; Toussaint M; Teodoro R; Dukić-Stefanović S; Kranz M; Deuther-Conrad W; Moldovan RP; Brust P
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33504051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiosynthesis and In Vitro Evaluation of [
    Humpert S; Schneider D; Lang M; Schulze A; Neumaier F; Holschbach M; Bier D; Neumaier B
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial.
    Hauser RA; Olanow CW; Kieburtz KD; Pourcher E; Docu-Axelerad A; Lew M; Kozyolkin O; Neale A; Resburg C; Meya U; Kenney C; Bandak S
    Lancet Neurol; 2014 Aug; 13(8):767-76. PubMed ID: 25008546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and preclinical evaluation of 2-(2-furanyl)-7-[2-[4-[4-(2-[11C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine-5-amine ([11C]Preladenant) as a PET tracer for the imaging of cerebral adenosine A2A receptors.
    Zhou X; Khanapur S; Huizing AP; Zijlma R; Schepers M; Dierckx RA; van Waarde A; de Vries EF; Elsinga PH
    J Med Chem; 2014 Nov; 57(21):9204-10. PubMed ID: 25279444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial.
    Hauser RA; Cantillon M; Pourcher E; Micheli F; Mok V; Onofrj M; Huyck S; Wolski K
    Lancet Neurol; 2011 Mar; 10(3):221-9. PubMed ID: 21315654
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y
    J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics modeling and occupancy studies of a novel C-11 PET tracer for VAChT in nonhuman primates.
    Jin H; Zhang X; Yue X; Liu H; Li J; Yang H; Flores H; Su Y; Parsons SM; Perlmutter JS; Tu Z
    Nucl Med Biol; 2016 Feb; 43(2):131-9. PubMed ID: 26872437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative Analysis of Tozadenant Using Liquid Chromatography-Mass Spectrometric Method in Rat Plasma and Its Human Pharmacokinetics Prediction Using Physiologically Based Pharmacokinetic Modeling.
    Lee BI; Park MH; Shin SH; Byeon JJ; Park Y; Kim N; Choi J; Shin YG
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel investigational adenosine A2A receptor antagonists for Parkinson's disease.
    Pinna A
    Expert Opin Investig Drugs; 2009 Nov; 18(11):1619-31. PubMed ID: 19888872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned.
    Hauser RA; Stocchi F; Rascol O; Huyck SB; Capece R; Ho TW; Sklar P; Lines C; Michelson D; Hewitt D
    JAMA Neurol; 2015 Dec; 72(12):1491-500. PubMed ID: 26523919
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K
    J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, tolerability and pharmacokinetics after single and multiple doses of preladenant (SCH420814) administered in healthy subjects.
    Cutler DL; Tendolkar A; Grachev ID
    J Clin Pharm Ther; 2012 Oct; 37(5):578-87. PubMed ID: 22676397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single Stabilizing Point Mutation Enables High-Resolution Co-Crystal Structures of the Adenosine A
    Claff T; Klapschinski TA; Tiruttani Subhramanyam UK; Vaaßen VJ; Schlegel JG; Vielmuth C; Voß JH; Labahn J; Müller CE
    Angew Chem Int Ed Engl; 2022 May; 61(22):e202115545. PubMed ID: 35174942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.